| *APC resistance Factor V Leiden mutation |
| *Ankylosing spondylitis (HLA B27) |
| Apolipoprotein E mutation (Dyslipidaemia) E2/E3/E4 |
| Cardiovascular genetic screen (ApoE, ApoB, MTHFR, FV, PTB, FXIII, B-Fibrinogen, PAI-1, HPAI, HFE) |
| Celiac susceptibility screen (HLA-DQ2/DQ8) |
| Detoxification-oxidation screen (GSTT1, GSTM1, MnSoD) |
| *Familial breast cancer (BRCA 1/2 – 3 population specific mutations) |
| *Familial hypercholesterolaemia (D154N, DeII97, D200G, D206E, C356Y, G36IV, V408M, P664L) |
| GenePro genetic screen (ApoE, MTHFR, FV, PTB, PAI-1, HFE, GNB3, PPARg, IL-6, TNFa, GSTT1, GSTM1, MnSOD, COMT) |
| Hereditary haemochromatosis (C282Y, H63D, S65C) |
| Hyperhomocysteinaemia (MTHFR C>T + 1298A>C mutations for methyltetrahydrofolate reductase) |
| Insulin resistance (PPARg) |
| Lactose intolerance (MCM6) |
| Muscle performance related mutation (ACTN3 R577X) |
| Thrombophilia (recurrent pregnancy loss) (FV Leiden, Prothrombin, FXIII, PAI-1, HPA-1, ß-fibrinogen, MTHFR) |
| Oestrogen exposure-detoxification screen (MTHFR, GSTT1, GSTM1, COMT, MnSOD) |
| Venous thrombosis (FV Leiden + Prothrombin) |
